Immediate Impact
47 standout
Citing Papers
Trials and Tribulations of MicroRNA Therapeutics
2024 Standout
Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials
2024 Standout
Works of Lacey Kruse being referenced
Integrating Next-Generation Sequencing with Morphology Improves Prognostic and Biologic Classification of Spitz Neoplasms
2020
The impact of pediatric skin disease on self-esteem
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lacey Kruse | 123 | 64 | 20 | 90 | 23 | 312 | |
| Yuan Liang | 74 | 44 | 12 | 39 | 35 | 288 | |
| Wilkinson Ds | 130 | 67 | 15 | 65 | 23 | 355 | |
| R. Corbalán-Vélez | 84 | 10 | 23 | 79 | 33 | 332 | |
| David Spoerl | 42 | 82 | 32 | 73 | 28 | 370 | |
| Lai‐San Wong | 107 | 47 | 15 | 71 | 20 | 362 | |
| Nordau Kanigsberg | 93 | 25 | 75 | 43 | 28 | 313 | |
| Keyun Tang | 182 | 21 | 10 | 22 | 29 | 330 | |
| Noriaki Shinomiya | 82 | 72 | 7 | 16 | 35 | 349 | |
| D. Kramer | 42 | 48 | 7 | 15 | 26 | 287 | |
| Chi‐Chang Shieh | 44 | 81 | 21 | 14 | 36 | 360 |
All Works
Login with ORCID to disown or claim papers
Loading papers...